Southwestern internal medicine conference

Mastocytosis: Developments during the past decade

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Mastocytosis is a spectrum of disorders characterized by an aberrant proliferation of tissue mast cells. Although this disease process often affects the skin, it may involve multiple organs. The clinical disorder varies according to patient age, the clinical manifestations demonstrated, and the extent of the mast cell proliferative process. A myriad of clinical symptoms occur, and these may be localized to the organ system involved or may be systemic, depending on whether there is local or generalized mast cell mediator release. Diagnosis includes the demonstration of increased tissue mast cells in involved organs as well as increased levels of biochemical mediators. Patients with cutaneous involvement only have the best prognosis. Treatment is directed toward stabilizing mast cell mediator release and blocking the effects of those mediators generated.

Original languageEnglish (US)
Pages (from-to)328-338
Number of pages11
JournalAmerican Journal of the Medical Sciences
Volume309
Issue number6
StatePublished - 1995

Fingerprint

Mastocytosis
Internal Medicine
Mast Cells
Choristoma
Skin

Keywords

  • Mast cell
  • Mast cell mediators
  • Mastocytosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{035fde2efc6745b2a522c234f064b046,
title = "Southwestern internal medicine conference: Mastocytosis: Developments during the past decade",
abstract = "Mastocytosis is a spectrum of disorders characterized by an aberrant proliferation of tissue mast cells. Although this disease process often affects the skin, it may involve multiple organs. The clinical disorder varies according to patient age, the clinical manifestations demonstrated, and the extent of the mast cell proliferative process. A myriad of clinical symptoms occur, and these may be localized to the organ system involved or may be systemic, depending on whether there is local or generalized mast cell mediator release. Diagnosis includes the demonstration of increased tissue mast cells in involved organs as well as increased levels of biochemical mediators. Patients with cutaneous involvement only have the best prognosis. Treatment is directed toward stabilizing mast cell mediator release and blocking the effects of those mediators generated.",
keywords = "Mast cell, Mast cell mediators, Mastocytosis",
author = "Gruchalla, {R. S.}",
year = "1995",
language = "English (US)",
volume = "309",
pages = "328--338",
journal = "The American journal of the medical sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Southwestern internal medicine conference

T2 - Mastocytosis: Developments during the past decade

AU - Gruchalla, R. S.

PY - 1995

Y1 - 1995

N2 - Mastocytosis is a spectrum of disorders characterized by an aberrant proliferation of tissue mast cells. Although this disease process often affects the skin, it may involve multiple organs. The clinical disorder varies according to patient age, the clinical manifestations demonstrated, and the extent of the mast cell proliferative process. A myriad of clinical symptoms occur, and these may be localized to the organ system involved or may be systemic, depending on whether there is local or generalized mast cell mediator release. Diagnosis includes the demonstration of increased tissue mast cells in involved organs as well as increased levels of biochemical mediators. Patients with cutaneous involvement only have the best prognosis. Treatment is directed toward stabilizing mast cell mediator release and blocking the effects of those mediators generated.

AB - Mastocytosis is a spectrum of disorders characterized by an aberrant proliferation of tissue mast cells. Although this disease process often affects the skin, it may involve multiple organs. The clinical disorder varies according to patient age, the clinical manifestations demonstrated, and the extent of the mast cell proliferative process. A myriad of clinical symptoms occur, and these may be localized to the organ system involved or may be systemic, depending on whether there is local or generalized mast cell mediator release. Diagnosis includes the demonstration of increased tissue mast cells in involved organs as well as increased levels of biochemical mediators. Patients with cutaneous involvement only have the best prognosis. Treatment is directed toward stabilizing mast cell mediator release and blocking the effects of those mediators generated.

KW - Mast cell

KW - Mast cell mediators

KW - Mastocytosis

UR - http://www.scopus.com/inward/record.url?scp=0029018564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029018564&partnerID=8YFLogxK

M3 - Article

VL - 309

SP - 328

EP - 338

JO - The American journal of the medical sciences

JF - The American journal of the medical sciences

SN - 0002-9629

IS - 6

ER -